We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Autonomous Robot Performs COVID-19 Nasal Swab Tests

By HospiMedica International staff writers
Posted on 11 Aug 2020
Print article
The NSR autonomously takes nasal samples (Photo courtesy of Brain Navi Biotechnology)
The NSR autonomously takes nasal samples (Photo courtesy of Brain Navi Biotechnology)
A new robotic system performs nasal swab tests on its own, helping to prevent cross infections among people being examined.

The Brain Navi Biotechnology (Hsinchu, Taiwan) Nasal Swab Robot (NSR) is designed to automatically, independently, recognize a patient's facial structure and identify the nostril's location, and subsequently take a sample of nasal secretions. The target population are suspected cases of whooping cough, diphtheria, influenza, and other types of diseases caused by the coronavirus family of viruses, including SARS, MERS, and COVID-19. The NSR is equipped with a compact robotic arm and display screen mounted on a wheeled trolley.

The procedure is based on three-dimensional imaging to identify facial and nasal characteristics, without the use of external frames, in order to move through nostrils, twirl the swab to collect a nasopharyngeal swab sample, remove it, and place it in a vial. With the aid of NSR, suspect patients can be tested safely around the clock, sparing medical health care workers the need to done personal protective equipment (PPE) and enter the high-risk environment during sample collecting. NSR could also allow autonomous specimen collection in airports, borders, drive-ins, or medical institutions.

“The SARS outbreak 17 years ago was a profound experience, but also left me deep wounds after losing a dear friend while we were saving lives. So, I decided to develop a robot to help save lives and be the first human to test NSR,” said Jerry Chen, MD, CEO of Brain Navi Biotechnology. “We feel the suffering of thousands of colleagues and patients worldwide with the pandemic. So, we developed the NSR in just eight weeks. We took some essential functions of our Autopilot Brain Surgical Navigation Robot.”

Testing for COVID-19 involves inserting a 15 centimeter long swab into the nasopharyngeal space, a cavity between the nose and mouth for 15 seconds, and rotating it several times. The swabbing is then repeated on the other side of the nose to make sure enough material is collected. The swab is then inserted into a container and sent to a lab for testing.

Related Links:

Brain Navi Biotechnology
Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Supplier
12-Channel ECG
CM1200B
New
Gold Supplier
Ultrasound System
FUTUS LE
New
Tissue Oximetry Sensor
ForeSight

Print article
Radcal

Channels

Critical Care

view channel
Image: The new blood test could prevent some of the 350,000 sepsis deaths in the U.S. annually (Photo courtesy of Cytovale)

Sepsis Test Could Save Lives in Emergency Departments, Study Suggests

Sepsis poses a severe, life-endangering illness that arises when an infection triggers a body-wide chain reaction, potentially causing multiple organs to fail quickly. Prompt and accurate diagnosis is... Read more

Surgical Techniques

view channel
Image: Suppressing production of an immune protein could reduce rejection of biomedical implants (Photo courtesy of 123RF)

Protein Identified for Immune Rejection of Biomedical Implants to Pave Way for Bio-Integrative Medical Devices

Biomedical implants like breast implants, pacemakers, and orthopedic devices have revolutionized healthcare, yet a substantial number of these implants face rejection by the body and have to be removed.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more

Business

view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.